Literature DB >> 21478830

Amgen spikes interest in live virus vaccines for hard-to-treat cancers.

Charlie Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21478830     DOI： 10.1038/nbt0411-295

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  11 in total

1.  Biotech's wellspring: a survey of the health of the private sector.

Authors:  Brady Huggett
Journal:  Nat Biotechnol       Date:  2012-05-07       Impact factor: 54.908

2.  Amgen announces oncolytic virus shrinks tumors.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2013-06       Impact factor: 54.908

3.  Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.

Authors:  Ji Young Yoo; Jason Pradarelli; Amy Haseley; Jeffrey Wojton; Azeem Kaka; Anna Bratasz; Christopher A Alvarez-Breckenridge; Jun-Ge Yu; Kimerly Powell; Andrew P Mazar; Theodoros N Teknos; E Antonio Chiocca; Joseph C Glorioso; Matthew Old; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2012-07-02       Impact factor: 12.531

Review 4.  Immunotherapeutic potential of oncolytic vaccinia virus.

Authors:  Steve H Thorne
Journal:  Immunol Res       Date:  2011-08       Impact factor: 4.505

5.  Regulating cytokine function enhances safety and activity of genetic cancer therapies.

Authors:  Hannah Chen; Padma Sampath; Weizhou Hou; Stephen H Thorne
Journal:  Mol Ther       Date:  2012-11-13       Impact factor: 11.454

6.  Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF.

Authors:  Weizhou Hou; Hannah Chen; Juan Rojas; Padma Sampath; Stephen H Thorne
Journal:  Int J Cancer       Date:  2014-02-18       Impact factor: 7.396

7.  Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activity.

Authors:  Jun Li; Mark O'Malley; Padma Sampath; Pawel Kalinski; David L Bartlett; Steve H Thorne
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

8.  Prostate cancer-specific and potent antitumor effect of a DD3-controlled oncolytic virus harboring the PTEN gene.

Authors:  Miao Ding; Xin Cao; Hai-neng Xu; Jun-kai Fan; Hong-ling Huang; Dong-qin Yang; Yu-hua Li; Jian Wang; Runsheng Li; Xin-yuan Liu
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

9.  Theranostic potential of oncolytic vaccinia virus.

Authors:  Juan J Rojas; Steve H Thorne
Journal:  Theranostics       Date:  2012-04-05       Impact factor: 11.556

10.  Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies.

Authors:  Juan J Rojas; Padma Sampath; Braulio Bonilla; Alexandra Ashley; Weizhou Hou; Daniel Byrd; Steve H Thorne
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.